Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease
نویسندگان
چکیده
منابع مشابه
Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease.
BACKGROUND Free circulating DNA (fcDNA) has been shown to be elevated in serum of prostate cancer patients compared with benign controls. However, studies evaluating the role of fcDNA as a biomarker in a "representative" patient group who have undergone prostate cancer screening are lacking. Our study examined the use of serum fcDNA levels as a biomarker of prostate cancer in such a setting. ...
متن کاملum Free Circulating DNA Is a Useful Biomarker to B & P inguish Benign versus Malignant Prostate Disease
ownloade kground: Free circulating DNA (fcDNA) has been shown to be elevated in serum of prostate cancer ts compared with benign controls. However, studies evaluating the role of fcDNA as a biomarker in a sentative” patient group who have undergone prostate cancer screening are lacking. Our study examhe use of serum fcDNA levels as a biomarker of prostate cancer in such a setting. thods: The st...
متن کاملUrinary neutrophil-gelatinase associated lipocalin is a more prognostic biomarker to distinguish antenatal hydronephrosis in neonates
Background: Routine diagnostic methods of Vesicoureteral reflux (VUR) are invasive and can cause exposure to radiation and may increase risk of urinary tract infections. Therefore, introducing reliable, non invasive methods might be more interested in pediatric nephrology. The objective of this perspective case control study was to evaluate the prognostic value of urinary neutrophil-gelatinase ...
متن کاملis serum prostate‑specifc antigen a diagnostic marker for benign and malignant breast tumors in women?
background: breast cancer is the most common cancer in women. prostate‑specifc antigen (psa) is a marker of prostate gland malignancy, which has been considered in cases with breast cancer in recent years. the goal of this study was to determine total and free psa levels in cases with malignant and benign breast lesions. methods: in this case–control study, ninety women with histological pr...
متن کاملBenign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease.
BACKGROUND BPSA is a "benign" form of free prostate-specific antigen (PSA) that is increased in prostate transition zone tissues of men with pathologic benign prostatic hyperplasia (BPH). We developed an immunoassay to determine the concentration of BPSA in the serum of men with BPH. METHODS The BPSA antigen was purified by HPLC, and murine monoclonal antibodies were prepared by standard meth...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 2015
ISSN: 0007-0920,1532-1827
DOI: 10.1038/bjc.2015.240